Effects of gait training with a voluntary driven Wearable Cyborg, Hybrid Assistive Limb (HAL), in patients with neuromuscular disease

Effects of gait training with a voluntary driven Wearable Cyborg, Hybrid Assistive Limb (HAL), in patients with neuromuscular disease - Treatment with Hybrid Assistive Limb in patients with neuromuscular disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000039240

Enrollment

Registered

2020-01-25

Start date

2017-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neuromuscular disease

Interventions

Gait training wearing HAL for 6 months. A single course of treatment included nine sessions of gait training for 4 weeks, and each patient completed two to four treatment courses.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients had para- or quadriparesis but were restricted only to those who were self-pedalable or walkable using a walker and had a sufficient stability of the trunk.

Exclusion criteria

Exclusion criteria: Patients with severe cardiovascular disease, or who cannot walk with assistance.

Design outcomes

Primary

Measure	Time frame
The parameters in 2-min walk test, a 10-m walk test, SF-36 questionnaire, and the Hospital Anxiety and Depression Scale (HADS) were measured before treatment, 1 month after treatment, and 6 months after treatment.	—

Countries

Japan

Contacts

Public ContactEiichi Tsuda

Hirosaki University, Graduate School of Medicine Dept. of Rehabilitation Medicine

eiichi@hirosaki-u.ac.jp0172-33-5111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026